Skip to content

Medical emergency? What to do

EU paves way for drugs modified for children

3-RXPublished June 1, 20062 min read

Key points

  • Drugs specifically adapted for pediatric use will become more widely available in the European Union starting next year, following the adoption of new rules released by the European Parliament on Thursday.
  • Many cancer drugs, such as carboplatin, are widely used to treat children on an "off-label" or unlicensed basis, cancer specialists say.
  • The new rules will cover medicines still in the development stage and not yet authorized as well as those already in use.
  • Medical experts said the rules were needed because children were physiologically different to adults.

Drugs specifically adapted for pediatric use will become more widely available in the European Union starting next year, following the adoption of new rules released by the European Parliament on Thursday.

More than half the medicines currently used to treat children have only been tested on adults and are not authorized for use specifically on infants, making it difficult for doctors to estimate the right dosage or predict side effects.

Many cancer drugs, such as carboplatin, are widely used to treat children on an "off-label" or unlicensed basis, cancer specialists say.

To tackle this, the European Commission drew up draft legislation that would require testing on children and, in exchange, drug companies would receive an extra six months of patent protection.

The new rules will cover medicines still in the development stage and not yet authorized as well as those already in use. Drug firms will have to submit a "pediatric investigation plan" to show how the treatment should be used for children.

Parliament adopted the legislation at second reading and the new rules will come into effect next January.

Medical experts said the rules were needed because children were physiologically different to adults.

"A member state on its own does not have the means to promote such a policy in favor of all our children," said Francoise Grossetete, the French center-right MEP who steered the legislation through parliament.

The EU is following in the footsteps of the United States, which introduced pediatric legislation in 1997 that led to new prescribing information and label changes on 44 drugs.

Generic drug makers, which stand to lose out from the extra exclusivity granted to branded medicine firms, fear the plan for six months of additional patent life is too generous.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug Abuse
Cancer

EU to take another look at GSK breast cancer drug

Europe's drugs regulators will take another look at GlaxoSmithKline Plc's new breast cancer pill Tyverb after new data showed a small risk of higher liver enzymes during treatment with the drug. GSK, Europe's biggest…

2 min read

Drug Abuse

Study raises caution on new painkillers

A new class of painkillers that block a receptor called TRPV1 may interfere with brain functions such as learning and memory, a new study suggests. The experiments with rat brain found that the TRPV1 receptor…

4 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.